{"id":"W2987471862","doi":"10.1186/s12933-019-0951-9","title":"Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies","year":2019,"lang":"en","type":"article","venue":"Cardiovascular Diabetology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Janssen Pharmaceuticals; Servier; Sanofi; Kowa Company; Novo Nordisk; National Institute for Health and Care Research; Medicines Company; University of California, San Diego; Regeneron Pharmaceuticals; Esperion Therapeutics; GlaxoSmithKline; NIHR Imperial Biomedical Research Centre; Amgen; Pfizer; Les Laboratories Pierre Fabre; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Dyslipidemia; Alirocumab; Medicine; Internal medicine; PCSK9; Endocrinology; Type 2 diabetes; Diabetes mellitus; Apolipoprotein B; Insulin; Cholesterol; Lipoprotein; Apolipoprotein A1; LDL receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002849052,0.0004869181,0.003674258,0.0004705673,0.0001164759,0.00002460148,0.0002370916,0.0002721708,0.00001713531],"category_scores_gemma":[0.000294212,0.0003129515,0.00211284,0.001806689,0.000587489,0.0001099192,0.0002225091,0.0004272061,0.000005033698],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001089547,"about_ca_system_score_gemma":0.0002082532,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001492311,"about_ca_topic_score_gemma":0.00002342241,"domain_scores_codex":[0.9954933,0.001068074,0.0006272838,0.001051253,0.001068433,0.000691645],"domain_scores_gemma":[0.9964167,0.0002166216,0.0001652779,0.002613383,0.0003187937,0.0002692126],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00008620055,0.00008496329,0.8389326,0.000639153,0.1140489,0.00002228916,0.0004978469,0.002688654,0.0001180533,0.00007639498,0.00001141431,0.04279356],"study_design_scores_gemma":[0.004771166,0.0003025904,0.969393,0.0002872371,0.01795371,0.00001888483,0.0003517192,0.0002793166,0.0003575454,0.00008736562,0.005807676,0.0003898506],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6372572,0.3610758,0.00002283364,0.0001396597,0.0001498424,0.001278629,0.0000152873,0.00002670648,0.00003408229],"genre_scores_gemma":[0.9592832,0.03995507,0.0001522305,0.0002543259,0.0001025519,0.0001395251,0.00002714283,0.00006387748,0.00002208148],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.322026,"threshold_uncertainty_score":0.9999322,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01772415958414966,"score_gpt":0.2509312485716827,"score_spread":0.233207088987533,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}